Zobrazeno 1 - 10
of 11
pro vyhledávání: '"B D, Curti"'
Autor:
D L, Longo, P L, Duffey, J G, Gribben, E S, Jaffe, B D, Curti, B L, Gause, J E, Janik, V M, Braman, D, Esseltine, W H, Wilson, D, Kaufman, R E, Wittes, L M, Nadler, W J, Urba
Publikováno v:
Cancer journal (Sudbury, Mass.). 6(3)
The purpose of this article was to evaluate the antitumor effects of a combination chemotherapy program based on ProMACE (prednisone, methotrexate, doxorubicin [Adriamycin], cyclophosphamide, etoposide) followed by a B cell-specific immunotoxin in th
Autor:
B, Arun, B D, Curti, D L, Longo, D, Stevens, W G, Alvord, B L, Gause, T, Watson, W C, Kopp, J E, Janik
Publikováno v:
The cancer journal from Scientific American. 6(1)
Interferon-alfa, 2'-deoxycoformycin, and 2-chlorodeoxy-adenosine (2-CdA) are effective in the management of patients with hairy cell leukemia. These agents produce remissions in most patients, but relapses occur with all three drugs. The optimal mean
Autor:
L L, Miller, E L, Korn, D S, Stevens, J E, Janik, B L, Gause, W C, Kopp, J T, Holmlund, B D, Curti, M, Sznol, J W, Smith, W J, Urba, S E, Donegan, T M, Watson, D L, Longo
Publikováno v:
Blood. 93(10)
This dose-escalation study was performed to evaluate the hematologic activity, biological effects, immunogenicity, and toxicity of PIXY321 (an interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein) administered after high-dose
Publikováno v:
American journal of hematology. 57(3)
The association of T-cell large granular lymphocyte (LGL) leukemia and rheumatoid arthritis is well described and it is now recognized that these patients and patients with Felty's syndrome represent different aspects of a single disease process. Mos
Autor:
M L, Saxton, D L, Longo, H E, Wetzel, H, Tribble, W G, Alvord, L W, Kwak, A S, Leonard, C D, Ullmann, B D, Curti, A C, Ochoa
Publikováno v:
Blood. 89(7)
The infusion of anti-CD3-activated murine T cells plus interleukin-2 (IL-2) exerts antitumor effects against several tumors in murine immunotherapy models. This study compares the therapeutic efficacy of anti-CD3-activated CD4+ or CD8+ T-cell subsets
Autor:
B. D. Curti, D. L. Longo
Publikováno v:
A Survey of Models for Tumor-Immune System Dynamics ISBN: 9781461264088
Our understanding of tumor biology and the immune system has expanded greatly in the last decade. This explosion of knowledge can be attributed to advances in molecular biology. Despite these advances, our success in devising effective therapy agains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7529f6df0ce23503b0f2e0d2e2cc9aa0
https://doi.org/10.1007/978-0-8176-8119-7_1
https://doi.org/10.1007/978-0-8176-8119-7_1
Autor:
B D, Curti
Publikováno v:
Cancer chemotherapy and biological response modifiers. 16
Autor:
A H, Zea, B D, Curti, D L, Longo, W G, Alvord, S L, Strobl, H, Mizoguchi, S P, Creekmore, J J, O'Shea, G C, Powers, W J, Urba
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 1(11)
We have recently described molecular changes in T cells from tumor-bearing patients that are associated with depressed immune function. The present work investigates changes in T-cell signal transduction proteins including the T-cell receptor-zeta (T
Publikováno v:
Cancer research. 53
Interstitial pressure (IP) is a physiological variable that may have its greatest influence on the transport of high-molecular-weight therapeutic agents. IP in tumor nodules was measured in patients with metastatic melanoma or non-Hodgkin's lymphoma
Autor:
L. Leopold, Timothy M. Kuzel, G. R. MacVicar, B. Poiesz, F. A. Greco, B. Somer, B. D. Curti, K. Brill, V. Gressler
Publikováno v:
Journal of Clinical Oncology. 26:16043-16043
16043 Background: Antiapoptotic Bcl-2 family proteins are overexpressed in HRPC and contribute to resistance to therapy. The oral pan-Bcl-2 inhibitor AT-101 (Bcl-2, Bcl-XL, Bcl-W, Mcl-1) is active as a single agent and in combination in in vitro and